UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Home therapy with recombinant interleukin-2 and interferon-α2b in advanced human malignancies

The Lancet (British edition), 1990-06, Vol.335 (8704), p.1509-1512

1990

Volltextzugriff (PDF)

Intravesical Therapy of Superficial Bladder T ransitional Cell Carcinoma with Tumor Necrosis Factor-Alpha: Preliminary Report of a Phase I—II Study

European urology, 1992-02, Vol.22 (2), p.112-114

1992

Volltextzugriff (PDF)

Interleukin-2 and Lymphokine-Activated Killer Cells in 15 Children With Advanced Metastatic Neuroblastoma

Journal of clinical oncology, 1992-06, Vol.10 (6), p.1026-1026

1992

Volltextzugriff (PDF)

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Annals of oncology, 1992-06, Vol.3 (6), p.475-480

1992

Volltextzugriff (PDF)

Cardioxane—ICRF-187 towards anticancer drug specificity through selective toxicity reduction

Cancer treatment reviews, 1991-03, Vol.18 (1), p.1-19

1991

Volltextzugriff (PDF)

The treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2

European journal of cancer (1990), 1994, Vol.30 (3), p.329-333

1994

Volltextzugriff (PDF)

A phase III study of recombinant interleukin-2, 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal carcinoma

European journal of cancer (1990), 1995, Vol.31 (1), p.19-25

1995

Volltextzugriff (PDF)

The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2

European journal of cancer (1990), 1994, Vol.30 (12), p.1804-1809

1994

Volltextzugriff (PDF)

A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma

European journal of cancer (1990), 1992, Vol.28 (2), p.443-446

1992

Volltextzugriff (PDF)

Tumour xenografts in mice

Franks, C.R

1983

Volltextzugriff (PDF)

Short report: Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-α

Annals of oncology, 1990-09, Vol.1 (5), p.377-378

1990

Volltextzugriff (PDF)

MYOCARDIAL INJURY AFTER INTERLEUKIN-2 THERAPY

The Lancet (British edition), 1988-07, Vol.332 (8601), p.48-49

1988

Volltextzugriff (PDF)

Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-alpha

Annals of oncology, 1990-09, Vol.1 (5), p.377-378

1990

Volltextzugriff (PDF)

Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patients

Cancer treatment reviews, 1989-06, Vol.16, p.91-104

1989

Volltextzugriff (PDF)

A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma

Cancer treatment reviews, 1989-06, Vol.16, p.163-167

1989

Volltextzugriff (PDF)

Combination IL-2 and cisplatinum: a promising treatment for bronchioloalveolar carcinoma?

European journal of cancer (1990), 1993, Vol.29 (13), p.1917-1918

1993

Volltextzugriff (PDF)

Reconstitution of interleukin-2

The Lancet (British edition), 1990-08, Vol.336 (8712), p.445-446

1990

Volltextzugriff (PDF)

Alternating recombinant human interleukin-2 and dacarbazine in advanced melanoma. A multicentric phase II study

Cancer treatment reviews, 1989-06, Vol.16, p.59-63

1989

Volltextzugriff (PDF)

A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma

Cancer chemotherapy and pharmacology, 1986-12, Vol.18 (3), p.286-288

1986

Volltextzugriff (PDF)

Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study

Cancer treatment reviews, 1989-06, Vol.16, p.111-113

1989

Volltextzugriff (PDF)

MYOCARDIAL INJURY AFTER INTERLEUKIN-2 THERAPY

The Lancet (British edition), 1989-03, Vol.333 (8639), p.674-674

1989

Volltextzugriff (PDF)

Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results

Cancer treatment reviews, 1989-06, Vol.16, p.161-162

1989

Volltextzugriff (PDF)

A phase-II study of adoptive immunotherapy with continuous infusion of interleukin-2 in children with advanced neuroblastoma. A report on 11 cases

Cancer treatment reviews, 1989-06, Vol.16, p.129-142

1989

Volltextzugriff (PDF)

Recombinant interleukin-2 continuous infusion in ovarian cancer patients with minimal residual disease at second-look

Cancer treatment reviews, 1989-06, Vol.16, p.123-127

1989

Volltextzugriff (PDF)

Prospective effect of norepinephrine infusion in acute renal insufficiency induced by interleukin 2 therapy

Nephron (2015), 1990, Vol.55 (4), p.438-439

1990

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(49)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(31)
Humans
(26)
Life Sciences & Biomedicine
(26)
Oncology
(18)
Middle Aged
(14)
Female
(13)
Interleukin-2 - Administration & Dosage
(12)
Male
(12)
Adult
(11)
Aged
(11)
Interleukin-2 - Adverse Effects
(9)
Biological And Medical Sciences
(8)
Drug Evaluation
(8)
Interleukin-2 - Therapeutic Use
(8)
Medical Sciences
(8)
Pharmacology. Drug Treatments
(8)
Recombinant Proteins - Administration & Dosage
(8)
Infusions, Intravenous
(7)
Antineoplastic Agents
(6)
Drug Administration Schedule
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Home therapy with recombinant interleukin-2 and interferon-α2b in advanced human malignancies

Intravesical Therapy of Superficial Bladder T ransitional Cell Carcinoma with Tumor Necrosis Factor-Alpha: Preliminary Report of a Phase I—II Study

Interleukin-2 and Lymphokine-Activated Killer Cells in 15 Children With Advanced Metastatic Neuroblastoma

Prognostic factors for survival in patients with advanced renal cell carcinoma treated with recombinant interleukin-2

Cardioxane—ICRF-187 towards anticancer drug specificity through selective toxicity reduction

The treatment of metastatic renal cell carcinoma by continuous intravenous infusion of recombinant interleukin-2

A phase III study of recombinant interleukin-2, 5-fluorouracil and leucovorin versus 5-fluorouracil and leucovorin in patients with unresectable or metastatic colorectal carcinoma

The development of anti-interleukin-2 (IL-2) antibodies in cancer patients treated with recombinant IL-2

A phase II study of sequential recombinant interleukin-2 followed by dacarbazine in metastatic melanoma

Tumour xenografts in mice

Short report: Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-α

MYOCARDIAL INJURY AFTER INTERLEUKIN-2 THERAPY

Treatment of metastatic renal cell cancer patients with recombinant subcutaneous human interleukin-2 and interferon-alpha

Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patients

A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma

Combination IL-2 and cisplatinum: a promising treatment for bronchioloalveolar carcinoma?

Reconstitution of interleukin-2

Alternating recombinant human interleukin-2 and dacarbazine in advanced melanoma. A multicentric phase II study

A phase II study of the platinum analogues JM8 and JM9 in malignant pleural mesothelioma

Metastatic renal cell cancer treated with low-dose interleukin-2. A phase-II multicentre study

MYOCARDIAL INJURY AFTER INTERLEUKIN-2 THERAPY

Interleukin-2 in malignant pleural mesothelioma (and adenocarcinoma of the lung). The use of intrapleural and continuous intravenous infusions: preliminary results

A phase-II study of adoptive immunotherapy with continuous infusion of interleukin-2 in children with advanced neuroblastoma. A report on 11 cases

Recombinant interleukin-2 continuous infusion in ovarian cancer patients with minimal residual disease at second-look

Prospective effect of norepinephrine infusion in acute renal insufficiency induced by interleukin 2 therapy

Suchergebnisse filtern